Control of home blood pressure with an amlodipine-or losartan-based regimen and progression of carotid artery intima-media thickness in hypertensive patients: The HOSP substudy

Clinical and Experimental Hypertension

Volumn 35, Issue 4, 2013, Pages 279-284

  Ohta, Yuko ^a   Kawano, Yuhei ^a   Iwashima, Yoshio ^a   Hayashi, Shinichiro ^a   Yoshihara, Fumiki ^a   Matayoshi, Tetsutaro ^a   Takiuchi, Shin ^a   Kamide, Kei ^a   Nakamura, Satoko ^a   Horio, Takeshi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Angiotensin receptor blocker; Calcium channel blocker; Carotid intima media thickness; Home blood pressure; Hypertension

Indexed keywords

AMLODIPINE; LOSARTAN;

ADULT; ARTERIAL WALL THICKNESS; BLOOD PRESSURE REGULATION; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; SYSTOLIC BLOOD PRESSURE;

AGED; AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; CAROTID INTIMA-MEDIA THICKNESS; CIRCADIAN RHYTHM; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; PILOT PROJECTS;

EID: 84879226511     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2013.780074     Document Type: Conference Paper

References (39)

1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration: age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
2. Kokubo Y, Nakamura S, Okamura T, et al. Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study. Stroke 2009; 40:2674-2679.
3. Turnbull F. Blood Pressure Lowering Treatment Trialists' Collaboration: effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectivelydesigned overviews of randomised trials. Lancet 2003; 362:1527-1535.
4. Arima H, Chalmers J, Woodward M, et al. PROGRESS Collaborative Group: lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens 2006; 24:1201-1208.
5. Tsunoda S, Kawano Y, Horio T, Okuda N, Takishita S. Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. Hypertens Res 2002; 25:167-173.
6. Bobrie G, Chatellier G, Genes N, et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349.
7. Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a strong predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohaasama, Japan. J Hypertens 1998; 16:971-975.
8. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population. Follow-up results from the Pressioni Arteriose Monitorate e Loro Assocciazioni (PAMELA) study. Circulation 2005; 111:1777-1783.
9. Hara A, Tanaka K, Ohkubo T, et al. Ambulatory versus home versus clinic blood pressure. The association with subclinical cerebrovascular disease: the Ohasama study. Hypertension 2012; 59:22-28.
10. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993; 153:598-615.
11. Pasty BM, Furberg CD, Kuller LH, et al. Association between blood pressure levels and the risk of myocardial infarction, stroke, and total mortality. Arch Intern Med 2001; 161:1183-1192.
12. Millar-Craig MW, Bishop CN, Raffery EB. Circadian variation of blood pressure. Lancet 1978; i:795-797.
13. Kawano Y. Diurnal blood pressure variation and related behavioral factors. Hypertens Res 2011; 34:281-285.
14. Mullaer JE,ToflerGH, StonePH.Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79:733-743.
15. Asayama K, Ohkubo T, Kikuya M, et al. Prediction of stroke by home "morning" versus "evening" blood pressure values: the Ohasama study. Hypertension 2006; 48:737-743.
16. Metoki H, Ohkubo T, Kikuya M, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 2006; 47:149-154.
17. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. A prospective study. Circulation 2003; 107:1401-1406.
18. Kawano Y, Mannami T, Saitoh D, et al. Hypertension control based on home systolic pressure (HOSP): study design and interim report. J Hypertens 2002; 20(suppl 4):S162.
19. Kawano Y, Horio T, Kamide K, Iwashima Y, Yoshihara F, Nakamura S. Blood pressure and medication during long-term antihypertensive therapy based on morning home SBP in hypertensive patients: Hypertension Control Based on Home Systolic Pressure (HOSP) substudy. Clin Exp Hypertens 2010; 32:239-243.
20. Takiuchi S, Kamide K, Miwa Y, et al. Diagnostic value of carotid intima-media thickness and plaque score for predicting target organ damage in patients with essential hypertension. J Hum Hypertens 2004; 18:17-23.
21. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation 1997; 96:1432-1437.
22. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37:87-92.
23. Chambless LE, Heiss G, Folson AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987-1993. Am J Epidemiol 1997; 146:483-494.
24. Tropeano AI, Saleh N, Hawajiri N, Macqquin-Mavier I, Maison P. Do all antihypertensive drugs improve carotid intima-media thickness? A network meta-analysis of randomized controlled trials. Fundam Clin Pharmacol 2011; 25:395-404.
25. Cuspidi C, Negri F, Giudici V, Capra A, Sala C. Effects of antihypertensive drugs on carotid intima-media thickness: focus on angiotensin II receptor blockers. A review of randomized, controlled trials. Integr Blood Press Control 2009; 2:1-8.
26. Paul J, Shaw K, Dasgupta S, Ghosh MK. Measurement of intima media thickness of carotid artery by B-mode ultrasound in healthy people of India and Bangladesh, and relation of age and sex with carotid artery intima media thickness: an observational study. J Cardiovasc Dis Res 2012; 3:128-131.
27. Howard G, Sharrett AR, Heiss G, et al. Carotid artery intimamedial thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 1993; 24:1297-1304.
28. Puato M, Palatini P, Zanardo M, et al. Increase in carotid intimamedia thickness in grade I hypertensive subjects. White-coat versus sustained hypertension. Hypertension 2006; 51:1300-1305.
29. Vasunta RL, Kesäniemi YA, Ylitalo A, Ukkola O. Nondipping pattern and carotid atherosclerosis in a middle-aged population: OPERA study. Am J Hypertens 2012; 25:60-66.
30. Kawano Y, Horio T, Kamide K, et al. Long-term effects of strict and modest control of home blood pressure with amlodipine-or losartan-based regimen on urinary albumin excretion in hypertensive patients: HOSP substudy. J Hypertens 2006; 24(suppl 6):343.
31. Asayama K, Ohkubo T,Metoki H, et al. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure. Hypertens Res 2012; 35:1102-1110.
32. Zhang X, Hintze TH. Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation 1998; 95:576-580.
33. Stepien O, Gogusev J, Zhu DL, et al. Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation. J Cardiovasc Pharmacol 1998; 31:786-793.
34. Kaschina E, Unger T. Angiotensin AT1/AT2 receptors: regulation, signaling and function. Blood Press 2003; 12:70-88.
35. Keaney JF. Oxidative stress and the vascular wall NADPH oxidases take center stage. Circulation 2005; 112:2585-2588.
36. Ikeda H, Minamikawa J, Nakamura Y, et al. Comparison of effects of amlodipine and angiotensin receptor blockers on the intimamedia thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study). Diabetes Res Clin Pract 2009; 83:50-53.
37. Straton AV, Chapman JN, Mayet J, et al. Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery. Clin Sci 2001; 101:455-464.
38. Terpstra WF, May JF, Smit AJ, et al. Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial). J Hypertens 2004; 22:1309-1316.
39. Wang JG, Staessen JA, Li Y, et al. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Stroke 2006; 37:1933-1940.